Dayana Itzel Urrutia

Senior clinical monitor for Takeda and Moderna pediatric infectious disease trials, ensuring GCP compliance, monitoring visits, and database lock readiness across multiple sites.

Senior clinical monitor for COVID and infectious disease vaccine studies, conducting site initiation, monitoring and close-out visits while supporting enrollment strategies.

Served as Medical Science Liaison across Latin American markets, facilitating medical education, stakeholder engagement, and scientific support for oncology products.

Independent senior clinical monitor for AstraZeneca observational oncology studies in Panama and Costa Rica, conducting qualification, monitoring, and close-out activities.

Senior clinical monitor for Roche studies in oncology, rheumatology and lupus nephritis (Phase II–IV), overseeing sites across Central America and ensuring data quality and regulatory compliance.

Managed Phase III study for treatment of cutaneous leishmaniasis across Panamanian provinces, conducting monitoring visits and ensuring protocol adherence and data integrity.

Supervised Phase III–IV vaccine and epidemiological studies across Latin America, ensuring study conduct, patient safety and data integrity.

Executed brachytherapy and external radiotherapy treatments, managed unit mechanics and patient CT simulations to ensure safe daily radiation delivery.

Pursuing a Master of Business Administration with emphasis on Strategic Management at Interamerican University of Panama since 2025.

Completed a Diploma in Health Economics at Universidad Latina from October 2023 to March 2024.

Completed a Pharmacovigilance course at HAACI in November 2024.

Completed an Agile Project Management course at Interamerican University of Panama in May–June 2024.

Completed a Project Management basis course focused on risk management through the Project Management Institute in September 2024.

Bachelor's degree in Biology with specialization in Microbiology and Parasitology from the University of Panama (1994–2001).